Sexual Health Testing Market - By Device Type (Laboratory Devices, Point of Care (PoC) Devices), By Application (Chlamydia, Gonorrhoea, Syphilis, Genital Herpes, Hepatitis B, HIV/AIDS), By End-use – Global Forecast to 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSexual Health Testing Market - By Device Type (Laboratory Devices, Point of Care (PoC) Devices), By Application (Chlamydia, Gonorrhoea, Syphilis, Genital Herpes, Hepatitis B, HIV/AIDS), By End-use – Global Forecast to 2032
Sexual Health Testing Market Size
Sexual Health Testing Market size was valued at over USD 90 billion in 2022 and is projected to register over 5.3% CAGR between 2023 and 2032 owing to rising awareness regarding STDs and its diagnosis.
Sexual health testing refers to the process of diagnosing and screening for sexually transmitted infections (STIs) and other conditions related to sexual health. Testing is crucial for identifying infections, determining appropriate treatment, and preventing the spread of diseases. Additionally, the high prevalence of sexually transmitted diseases (STDs) is accelerating market growth. For instance, STDs have a substantial global impact, affecting millions of people each year. According to the World Health Organization (WHO), there are an estimated 376 million new cases of four common sexually transmitted infections including gonorrhoea, chlamydia, syphilis, and trichomoniasis, annually.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Sexual Health Testing Market Size in 2022 | USD 90 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 5.3% |
| 2032 Value Projection | USD 152 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 200 |
| Tables, Charts & Figures | 277 |
| Segments covered | Device type, Application, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Moreover, STD prevalence rate can vary significantly between regions and countries. Factors such as socioeconomic conditions, healthcare infrastructure, education, cultural norms, and sexual behaviours contribute to these variations. Additionally, stigma associated with STDs and sexual health, lack of awareness, and limited access to healthcare services can function as barriers to testing and prevention. Thus, regular microbiology testing, early diagnosis, and timely treatment are crucial for reducing the prevalence of STDs, thereby augmenting STD diagnostics market growth. In addition, several market players are emphasizing on research and development activities for the development of novel sexual health testing.
COVID-19 Impact
The COVID-19 epidemic had a moderately negative impact on the sexual health testing market. The pandemic led to disruptions in healthcare systems globally, with resources and attention primarily focused on managing and responding to COVID-19. This resulted in reduced availability and access to routine sexual health services, including testing. Due to the overwhelming demand for COVID-19 testing and vaccination efforts, resources and healthcare personnel were redirected to pandemic-related activities. This diversion of resources affected the overall capacity for sexual health testing.
However, post pandemic to adapt to the challenges posed by the pandemic, healthcare providers have increasingly adopted telemedicine and remote testing options. These may include virtual consultations, home testing kits for certain infections, and remote monitoring of sexual health conditions. Such innovations have helped bridge the gap in access to sexual health testing. Therefore, COVID-19 pandemic hindered the STD diagnostics market growth.
Sexual Health Testing Market Trends
Increasing government initiatives towards sexually transmitted diseases (STDs) are crucial in addressing the challenges associated with these infections. Governments worldwide have recognized the importance of prevention, awareness, testing, treatment, and support services for individuals affected by STDs. Governments often promote and support vaccination programs for diseases such as human papillomavirus (HPV) and hepatitis B virus (HBV), which can be sexually transmitted. These programs target specific age groups, such as adolescents, to protect individuals before they become sexually active. Thus, such initiatives will lead to high product demand in the near future.
Sexual Health Testing Market Analysis
Imagine you need to get tested for a sexually transmitted infection. There are two main types of testing devices you can usethose used in a lab and those you can use at home (called point-of-care devices). Lab tests are like the big machines you see in hospitals. They can do tests like PCR, which is a fancy way of saying they can make lots of copies of a tiny piece of your DNA to check for infections. They can also use other methods like flow cytometry, ELISA, and others. Home tests, or point-of-care tests, are more like the little test kits you buy at the pharmacy. They're smaller and easier to use. They usually use a technique called rapid diagnostics or microfluidics and immunochromatographic testing (ICT). In 2022, the labs had the most business, bringing in more than 60 billion dollars. Lab tests are often more accurate and sensitive than home tests, so doctors tend to rely on them for important decisions. They can pick up on even tiny signs of infection.
Laboratory tests undergo rigorous validation and quality control measures, ensuring reliable and precise results. Furthermore, an increase in the availability of device type coupled with several other businesses working towards creating innovative technology will support the segment's revenue growth.
STD diagnostics market is bifurcated based on the application including chlamydia, gonorrhoea, syphilis, genital herpes, hepatitis B, HIV/AIDS, others. The chlamydia segment dominated the market and is anticipated to grow over USD 36 billion by 2032. Chlamydia is one of the most commonly reported sexually transmitted infections (STIs) worldwide, and its prevalence has been increasing over the years. For instance, according to the World Health Organization (WHO), an estimated 127 million new cases of chlamydia occur, annually.
Imagine the healthcare industry as a pie. The slice of that pie that's all about sexual health testing is actually divided into three main chunkshospitals, diagnostic centers, and everything else. Among these slices, diagnostic centers are the biggest, taking up over half the pie in 2022. And the good news is, they're expected to keep growing, potentially raking in over $82 billion by 2032. Diagnostic centers are popular because they're the go-to spot for lab tests. And with all the fancy equipment and affordable prices, more and more people are choosing them for their health check-ups. Plus, these centers are like health detectives, helping to diagnose diseases early and getting patients on the right track to treatment. No wonder they're the star performers in the sexual health testing world!
The market for sexual health testing in the U.S. has been booming. In 2022, it was worth a whopping $33 billion. And it's only going to keep growing, expected to reach over $55 billion by 2032. This surge is mainly due to two reasons. First, sexual health testing has become more affordable for more people. Second, technology has made it easier and more accurate to test for sexually transmitted diseases (STDs). The U.S. is a particularly good market for this industry. Americans spend more on healthcare than any other country. And they also have a lot of disposable income, which means they're more likely to spend money on health-related products and services. There are also a lot of well-known companies that make sexual health testing products. And the government has made it easier for them to get their products approved and launched. This has led to a wide variety of testing options available to consumers.
Sexual Health Testing Market Share
Some of the notable key industry players operating in the sexual health testing market include
- bioMérieux SA
- Hologic, Inc.
- OraSure Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Merck & Co. Inc.
- Johnson & Johnson Services, Inc
- GlaxoSmithKline Plc.
- Allergen
- Bayer AG
- Bristol-Myers Squibb Company
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Sorrento Therapeutics, Inc.
- WEX Pharmaceuticals Inc.
- Zynerba Pharmaceuticals, Inc.
- Medtronic Inc.
- Boston Scientific Corporation
- Halyard Health, Inc.
- Neurotech Na, Inc.
Sexual Health Testing Industry News
- In February 2023, BD received U.S. FDA approval for its product called Onclarity HPV Assay that is used along with ThinPrep PAP test. The test detects HPV types 16,18, 45 along with genotypes 31, 51, 52, 33/58, 35/39/68, and 56/59/66. Such advanced product launches are anticipated to bolster STD diagnostics market statistics.
Sexual health testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Device Type (USD Million)
- Laboratory devices
- PCR (Polymerase Chain Reaction)
- Flow cytometers
- Enzyme linked immunosorbent assay (ELISA)
- Others
- Point of care (PoC) devices
- Microfluidics and immunochromatographic testing (ICT)
- Rapid diagnostic kits
By Application (USD Million)
- Chlamydia
- Gonorrhoea
- Syphilis
- Genital herpes
- Hepatitis B
- HIV/AIDS (Human immunodeficiency virus infection and acquired immune deficiency syndrome)
By End-use (USD Million)
- Hospitals
- Diagnostic centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy